Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-014248
Filing Date
2007-01-26
Accepted
2007-01-26 16:21:38
Documents
7
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 183948
2 COPROMOTION AND MARKETING SERVICES AGREEMENT dex10163.htm EX-10.163 147912
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 2109
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9242
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9362
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2950
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2961
  Complete submission text file 0001193125-07-014248.txt   359978
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Filer) CIK: 0000854222 (see all company filings)

EIN.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-18728 | Film No.: 07556908
SIC: 2834 Pharmaceutical Preparations